

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 7.24964002 |
| 2 | positive T cell selection (GO:0043368) | 7.12366766 |
| 3 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 6.33978683 |
| 4 | sphingomyelin metabolic process (GO:0006684) | 6.09158320 |
| 5 | positive thymic T cell selection (GO:0045059) | 6.08527949 |
| 6 | eosinophil chemotaxis (GO:0048245) | 5.99763569 |
| 7 | negative T cell selection (GO:0043383) | 5.95773099 |
| 8 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 5.87245211 |
| 9 | positive regulation of tolerance induction (GO:0002645) | 5.76200305 |
| 10 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 5.53133993 |
| 11 | cellular response to interleukin-15 (GO:0071350) | 5.47034573 |
| 12 | eosinophil migration (GO:0072677) | 5.39512879 |
| 13 | negative regulation by host of viral transcription (GO:0043922) | 5.35565486 |
| 14 | regulation of T cell tolerance induction (GO:0002664) | 5.34355704 |
| 15 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.13543891 |
| 16 | negative thymic T cell selection (GO:0045060) | 5.06642292 |
| 17 | cytidine deamination (GO:0009972) | 4.93691884 |
| 18 | cytidine metabolic process (GO:0046087) | 4.93691884 |
| 19 | cytidine catabolic process (GO:0006216) | 4.93691884 |
| 20 | macrophage chemotaxis (GO:0048246) | 4.91285380 |
| 21 | thymic T cell selection (GO:0045061) | 4.83794823 |
| 22 | T cell selection (GO:0045058) | 4.81883945 |
| 23 | regulation of lymphocyte chemotaxis (GO:1901623) | 4.71758110 |
| 24 | auditory receptor cell differentiation (GO:0042491) | 4.70403779 |
| 25 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.69958516 |
| 26 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.66689729 |
| 27 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 4.52247819 |
| 28 | regulation of tolerance induction (GO:0002643) | 4.48239494 |
| 29 | negative regulation of monooxygenase activity (GO:0032769) | 4.45516044 |
| 30 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.38715583 |
| 31 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.34568850 |
| 32 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 4.29517027 |
| 33 | response to interleukin-15 (GO:0070672) | 4.28075221 |
| 34 | negative regulation of T cell differentiation in thymus (GO:0033085) | 4.27849638 |
| 35 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.18178427 |
| 36 | DNA deamination (GO:0045006) | 4.13422740 |
| 37 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.10417224 |
| 38 | positive regulation of calcium-mediated signaling (GO:0050850) | 4.05480595 |
| 39 | positive regulation of macrophage differentiation (GO:0045651) | 4.00195005 |
| 40 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.95174782 |
| 41 | negative regulation of cell fate specification (GO:0009996) | 3.93993387 |
| 42 | T cell receptor signaling pathway (GO:0050852) | 3.90974099 |
| 43 | T cell migration (GO:0072678) | 3.84005042 |
| 44 | positive regulation of T cell apoptotic process (GO:0070234) | 3.82547149 |
| 45 | positive regulation of fatty acid oxidation (GO:0046321) | 3.80710916 |
| 46 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 3.80524357 |
| 47 | histone H2A acetylation (GO:0043968) | 3.75571292 |
| 48 | sulfation (GO:0051923) | 3.71882247 |
| 49 | negative regulation of oxidoreductase activity (GO:0051354) | 3.71623966 |
| 50 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.70820075 |
| 51 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.68684168 |
| 52 | mechanosensory behavior (GO:0007638) | 3.65621886 |
| 53 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 3.65195879 |
| 54 | regulation of vitamin metabolic process (GO:0030656) | 3.60680107 |
| 55 | negative regulation of cell killing (GO:0031342) | 3.59742503 |
| 56 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.59742503 |
| 57 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.59609173 |
| 58 | protein prenylation (GO:0018342) | 3.54471008 |
| 59 | prenylation (GO:0097354) | 3.54471008 |
| 60 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.51104272 |
| 61 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.51104272 |
| 62 | GMP metabolic process (GO:0046037) | 3.50769871 |
| 63 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.48254910 |
| 64 | positive regulation of lymphocyte migration (GO:2000403) | 3.43726790 |
| 65 | necroptotic process (GO:0070266) | 3.43698683 |
| 66 | mast cell degranulation (GO:0043303) | 3.37033216 |
| 67 | mast cell activation involved in immune response (GO:0002279) | 3.37033216 |
| 68 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.31482950 |
| 69 | cytolysis (GO:0019835) | 3.30788209 |
| 70 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.28233543 |
| 71 | regulation of B cell differentiation (GO:0045577) | 3.28075644 |
| 72 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.21601124 |
| 73 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.20729591 |
| 74 | cellular defense response (GO:0006968) | 3.10829738 |
| 75 | negative regulation of T cell apoptotic process (GO:0070233) | 3.09762581 |
| 76 | regulation of T cell chemotaxis (GO:0010819) | 3.09366908 |
| 77 | positive regulation of T cell chemotaxis (GO:0010820) | 3.09366908 |
| 78 | granulocyte activation (GO:0036230) | 3.08581443 |
| 79 | leukocyte degranulation (GO:0043299) | 3.05186885 |
| 80 | respiratory burst (GO:0045730) | 3.03359227 |
| 81 | N-glycan processing (GO:0006491) | 3.02892127 |
| 82 | Peyers patch development (GO:0048541) | 3.01707377 |
| 83 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.01707377 |
| 84 | positive regulation of cell fate commitment (GO:0010455) | 2.99302034 |
| 85 | negative regulation of viral transcription (GO:0032897) | 2.99098863 |
| 86 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.98252471 |
| 87 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.98252471 |
| 88 | positive regulation of cell killing (GO:0031343) | 2.93077412 |
| 89 | actin nucleation (GO:0045010) | 2.92795437 |
| 90 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.92285563 |
| 91 | modulation by host of symbiont transcription (GO:0052472) | 2.89816407 |
| 92 | modulation by host of viral transcription (GO:0043921) | 2.89816407 |
| 93 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.89705284 |
| 94 | regulation of gamma-delta T cell activation (GO:0046643) | 2.88675108 |
| 95 | dopamine biosynthetic process (GO:0042416) | 2.88292223 |
| 96 | cytoplasmic sequestering of transcription factor (GO:0042994) | 2.86809031 |
| 97 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.86592081 |
| 98 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.85805826 |
| 99 | C21-steroid hormone biosynthetic process (GO:0006700) | 2.85540268 |
| 100 | regulation of B cell receptor signaling pathway (GO:0050855) | 10.8903916 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.96038740 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.51935140 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.36302381 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.01585524 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.92650349 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.29989083 |
| 7 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.29598856 |
| 8 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.29207377 |
| 9 | MYB_26560356_Chip-Seq_TH2_Human | 2.89946470 |
| 10 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.83534627 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.78248941 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.77966640 |
| 13 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.63760364 |
| 14 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.59135273 |
| 15 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.57594366 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.40765383 |
| 17 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.32276603 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.29407851 |
| 19 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.12097205 |
| 20 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 2.10676698 |
| 21 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.07155958 |
| 22 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.92556269 |
| 23 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.90345414 |
| 24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.85134555 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.77275165 |
| 26 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.77018760 |
| 27 | GATA3_26560356_Chip-Seq_TH2_Human | 1.74564156 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.68579149 |
| 29 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.68088485 |
| 30 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.68081712 |
| 31 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.65436505 |
| 32 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.63460700 |
| 33 | MYB_26560356_Chip-Seq_TH1_Human | 1.63190620 |
| 34 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.55767628 |
| 35 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.53832210 |
| 36 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.50579596 |
| 37 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.43377999 |
| 38 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.42814820 |
| 39 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.42742904 |
| 40 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.40350340 |
| 41 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.36041452 |
| 42 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.34019378 |
| 43 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.31706437 |
| 44 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.31372059 |
| 45 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.28137344 |
| 46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24693360 |
| 47 | MAF_26560356_Chip-Seq_TH1_Human | 1.23986096 |
| 48 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.21930304 |
| 49 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.17331997 |
| 50 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.12972361 |
| 51 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.10904132 |
| 52 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.10899580 |
| 53 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10388423 |
| 54 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.08058362 |
| 55 | GATA3_26560356_Chip-Seq_TH1_Human | 1.08011237 |
| 56 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.07930861 |
| 57 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.07234359 |
| 58 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.03861636 |
| 59 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01200609 |
| 60 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.00590314 |
| 61 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.00334097 |
| 62 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.99595119 |
| 63 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.99358845 |
| 64 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.99258093 |
| 65 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99221123 |
| 66 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.98849164 |
| 67 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98150275 |
| 68 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.96041370 |
| 69 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.95911543 |
| 70 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.95106072 |
| 71 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.94615962 |
| 72 | VDR_22108803_ChIP-Seq_LS180_Human | 0.94613897 |
| 73 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.94316396 |
| 74 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.93526536 |
| 75 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.93298967 |
| 76 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.93075245 |
| 77 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92887220 |
| 78 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.91334707 |
| 79 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.90555024 |
| 80 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.88879958 |
| 81 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.87612641 |
| 82 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86458056 |
| 83 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86229932 |
| 84 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.85921021 |
| 85 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85117969 |
| 86 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.84883325 |
| 87 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.83234622 |
| 88 | MAF_26560356_Chip-Seq_TH2_Human | 0.83103342 |
| 89 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.82622833 |
| 90 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.82068746 |
| 91 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.81402711 |
| 92 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.81031115 |
| 93 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.80896449 |
| 94 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.80044714 |
| 95 | UTX_26944678_Chip-Seq_JUKART_Human | 0.79580055 |
| 96 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.79391244 |
| 97 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.79337488 |
| 98 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.79193737 |
| 99 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.78926276 |
| 100 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.78268984 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 6.85391183 |
| 2 | MP0003763_abnormal_thymus_physiology | 5.85575717 |
| 3 | MP0005671_abnormal_response_to | 4.09570133 |
| 4 | MP0001873_stomach_inflammation | 4.02849474 |
| 5 | MP0008260_abnormal_autophagy | 3.64612946 |
| 6 | MP0000569_abnormal_digit_pigmentation | 3.00951795 |
| 7 | MP0006082_CNS_inflammation | 2.71787858 |
| 8 | MP0005387_immune_system_phenotype | 2.67715291 |
| 9 | MP0001790_abnormal_immune_system | 2.67715291 |
| 10 | MP0009333_abnormal_splenocyte_physiolog | 2.54063544 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.42045027 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.41058155 |
| 13 | MP0003283_abnormal_digestive_organ | 2.41052852 |
| 14 | MP0005503_abnormal_tendon_morphology | 2.27952096 |
| 15 | MP0001800_abnormal_humoral_immune | 2.21593734 |
| 16 | MP0005275_abnormal_skin_tensile | 2.16259851 |
| 17 | MP0002933_joint_inflammation | 2.05881143 |
| 18 | MP0003436_decreased_susceptibility_to | 1.99170673 |
| 19 | MP0002420_abnormal_adaptive_immunity | 1.98310772 |
| 20 | MP0001819_abnormal_immune_cell | 1.94512548 |
| 21 | MP0002723_abnormal_immune_serum | 1.94468205 |
| 22 | MP0000703_abnormal_thymus_morphology | 1.88411833 |
| 23 | MP0004742_abnormal_vestibular_system | 1.80472545 |
| 24 | MP0000685_abnormal_immune_system | 1.78164172 |
| 25 | MP0002166_altered_tumor_susceptibility | 1.74301794 |
| 26 | MP0002405_respiratory_system_inflammati | 1.70000735 |
| 27 | MP0009785_altered_susceptibility_to | 1.68688691 |
| 28 | MP0003866_abnormal_defecation | 1.67136424 |
| 29 | MP0000716_abnormal_immune_system | 1.63499514 |
| 30 | MP0002452_abnormal_antigen_presenting | 1.63211621 |
| 31 | MP0001485_abnormal_pinna_reflex | 1.62627580 |
| 32 | MP0002398_abnormal_bone_marrow | 1.59819077 |
| 33 | MP0003183_abnormal_peptide_metabolism | 1.59384568 |
| 34 | MP0005025_abnormal_response_to | 1.53858577 |
| 35 | MP0010386_abnormal_urinary_bladder | 1.53048698 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.51489232 |
| 37 | MP0001542_abnormal_bone_strength | 1.44229282 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.42188855 |
| 39 | MP0002148_abnormal_hypersensitivity_rea | 1.41272108 |
| 40 | MP0002876_abnormal_thyroid_physiology | 1.38939546 |
| 41 | MP0002722_abnormal_immune_system | 1.37251671 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.31750027 |
| 43 | MP0003786_premature_aging | 1.30095181 |
| 44 | MP0001666_abnormal_nutrient_absorption | 1.28394153 |
| 45 | MP0003938_abnormal_ear_development | 1.26997157 |
| 46 | MP0003448_altered_tumor_morphology | 1.25950123 |
| 47 | MP0005075_abnormal_melanosome_morpholog | 1.24719711 |
| 48 | MP0002277_abnormal_respiratory_mucosa | 1.22336856 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.21230117 |
| 50 | MP0001188_hyperpigmentation | 1.20112572 |
| 51 | MP0002419_abnormal_innate_immunity | 1.18448894 |
| 52 | MP0005389_reproductive_system_phenotype | 1.18317613 |
| 53 | MP0001919_abnormal_reproductive_system | 1.16295648 |
| 54 | MP0000681_abnormal_thyroid_gland | 1.14118396 |
| 55 | MP0002006_tumorigenesis | 1.14082008 |
| 56 | MP0002429_abnormal_blood_cell | 1.11542993 |
| 57 | MP0000604_amyloidosis | 1.03288620 |
| 58 | MP0005408_hypopigmentation | 1.01861107 |
| 59 | MP0003195_calcinosis | 1.01494310 |
| 60 | MP0004381_abnormal_hair_follicle | 1.00246080 |
| 61 | MP0006072_abnormal_retinal_apoptosis | 0.98559337 |
| 62 | MP0004883_abnormal_blood_vessel | 0.98200519 |
| 63 | MP0002282_abnormal_trachea_morphology | 0.97519007 |
| 64 | MP0001243_abnormal_dermal_layer | 0.96948966 |
| 65 | MP0004947_skin_inflammation | 0.96363609 |
| 66 | MP0008438_abnormal_cutaneous_collagen | 0.91088504 |
| 67 | MP0005551_abnormal_eye_electrophysiolog | 0.89088550 |
| 68 | MP0008007_abnormal_cellular_replicative | 0.85250715 |
| 69 | MP0005464_abnormal_platelet_physiology | 0.84900955 |
| 70 | MP0001905_abnormal_dopamine_level | 0.84174004 |
| 71 | MP0002998_abnormal_bone_remodeling | 0.81523524 |
| 72 | MP0002160_abnormal_reproductive_system | 0.81174958 |
| 73 | MP0000013_abnormal_adipose_tissue | 0.79981959 |
| 74 | MP0000858_altered_metastatic_potential | 0.79155368 |
| 75 | MP0003252_abnormal_bile_duct | 0.78890870 |
| 76 | MP0002108_abnormal_muscle_morphology | 0.75341840 |
| 77 | MP0001984_abnormal_olfaction | 0.72665473 |
| 78 | MP0005645_abnormal_hypothalamus_physiol | 0.71473074 |
| 79 | MP0003567_abnormal_fetal_cardiomyocyte | 0.70927301 |
| 80 | MP0008569_lethality_at_weaning | 0.69670962 |
| 81 | MP0003724_increased_susceptibility_to | 0.69310149 |
| 82 | MP0005023_abnormal_wound_healing | 0.67816287 |
| 83 | MP0005390_skeleton_phenotype | 0.66326634 |
| 84 | MP0002019_abnormal_tumor_incidence | 0.66058187 |
| 85 | MP0001986_abnormal_taste_sensitivity | 0.65559737 |
| 86 | MP0001663_abnormal_digestive_system | 0.64285657 |
| 87 | MP0005058_abnormal_lysosome_morphology | 0.60373966 |
| 88 | MP0005253_abnormal_eye_physiology | 0.59550924 |
| 89 | MP0001191_abnormal_skin_condition | 0.58971689 |
| 90 | MP0001765_abnormal_ion_homeostasis | 0.58777735 |
| 91 | MP0005164_abnormal_response_to | 0.58774884 |
| 92 | MP0000371_diluted_coat_color | 0.57401417 |
| 93 | MP0009115_abnormal_fat_cell | 0.56974913 |
| 94 | MP0002136_abnormal_kidney_physiology | 0.55320553 |
| 95 | MP0002132_abnormal_respiratory_system | 0.54264973 |
| 96 | MP0001270_distended_abdomen | 0.52535197 |
| 97 | MP0009763_increased_sensitivity_to | 0.52112209 |
| 98 | MP0001958_emphysema | 0.48769086 |
| 99 | MP0003690_abnormal_glial_cell | 0.45673293 |
| 100 | MP0001502_abnormal_circadian_rhythm | 0.43994269 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Gastrointestinal infarctions (HP:0005244) | 6.74513736 |
| 2 | B lymphocytopenia (HP:0010976) | 6.66306449 |
| 3 | T lymphocytopenia (HP:0005403) | 6.31132888 |
| 4 | Abnormality of B cell number (HP:0010975) | 5.93619171 |
| 5 | Abnormality of T cell number (HP:0011839) | 5.79692093 |
| 6 | Thyroiditis (HP:0100646) | 4.75836761 |
| 7 | Autoimmune hemolytic anemia (HP:0001890) | 4.67266982 |
| 8 | Aortic dissection (HP:0002647) | 4.57168911 |
| 9 | IgG deficiency (HP:0004315) | 4.21270772 |
| 10 | Diplopia (HP:0000651) | 4.19987860 |
| 11 | Abnormality of binocular vision (HP:0011514) | 4.19987860 |
| 12 | Severe combined immunodeficiency (HP:0004430) | 4.16255755 |
| 13 | Increased IgM level (HP:0003496) | 3.97566812 |
| 14 | Hypoplasia of the thymus (HP:0000778) | 3.87157610 |
| 15 | Abnormality of the prostate (HP:0008775) | 3.85086082 |
| 16 | Combined immunodeficiency (HP:0005387) | 3.74874447 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 3.53059954 |
| 18 | Stomatitis (HP:0010280) | 3.50521899 |
| 19 | Lymphopenia (HP:0001888) | 3.49282179 |
| 20 | Increased corneal curvature (HP:0100692) | 3.47608477 |
| 21 | Keratoconus (HP:0000563) | 3.47608477 |
| 22 | Spondylolisthesis (HP:0003302) | 3.45441992 |
| 23 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.41442297 |
| 24 | Interstitial pulmonary disease (HP:0006530) | 3.35556647 |
| 25 | Abnormality of eosinophils (HP:0001879) | 3.34187219 |
| 26 | Ureteral stenosis (HP:0000071) | 3.33936721 |
| 27 | Ureteral obstruction (HP:0006000) | 3.26026197 |
| 28 | Chronic diarrhea (HP:0002028) | 3.25836031 |
| 29 | Chest pain (HP:0100749) | 3.25589201 |
| 30 | Abnormality of T cells (HP:0002843) | 3.25395993 |
| 31 | Amaurosis fugax (HP:0100576) | 3.24561196 |
| 32 | Recurrent bronchitis (HP:0002837) | 3.24460502 |
| 33 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.17480422 |
| 34 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.03525078 |
| 35 | Decreased central vision (HP:0007663) | 2.98392139 |
| 36 | Hypoproteinemia (HP:0003075) | 2.98022121 |
| 37 | Obstructive lung disease (HP:0006536) | 2.91061309 |
| 38 | Chronic obstructive pulmonary disease (HP:0006510) | 2.91061309 |
| 39 | Arterial thrombosis (HP:0004420) | 2.86566918 |
| 40 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.82812509 |
| 41 | Recurrent cutaneous fungal infections (HP:0011370) | 2.82812509 |
| 42 | Attenuation of retinal blood vessels (HP:0007843) | 2.82440405 |
| 43 | Encephalitis (HP:0002383) | 2.80781650 |
| 44 | Hemoptysis (HP:0002105) | 2.77109213 |
| 45 | Hemiplegia (HP:0002301) | 2.73032993 |
| 46 | Gangrene (HP:0100758) | 2.71870393 |
| 47 | Meningitis (HP:0001287) | 2.68953463 |
| 48 | Leukocytosis (HP:0001974) | 2.68109621 |
| 49 | Pulmonary infiltrates (HP:0002113) | 2.63501753 |
| 50 | Alveolar cell carcinoma (HP:0006519) | 2.61168341 |
| 51 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.60035160 |
| 52 | Abnormality of alanine metabolism (HP:0010916) | 2.60035160 |
| 53 | Hyperalaninemia (HP:0003348) | 2.60035160 |
| 54 | Subacute progressive viral hepatitis (HP:0006572) | 2.59716174 |
| 55 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.54121191 |
| 56 | Eosinophilia (HP:0001880) | 2.43130863 |
| 57 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.40699835 |
| 58 | Vasculitis (HP:0002633) | 2.38480155 |
| 59 | Pancytopenia (HP:0001876) | 2.37795043 |
| 60 | Joint swelling (HP:0001386) | 2.34737950 |
| 61 | Hepatitis (HP:0012115) | 2.34514408 |
| 62 | Bronchitis (HP:0012387) | 2.33605970 |
| 63 | Recurrent fungal infections (HP:0002841) | 2.30690688 |
| 64 | IgM deficiency (HP:0002850) | 2.30218981 |
| 65 | Acute hepatic failure (HP:0006554) | 2.27479274 |
| 66 | Abnormality of macrophages (HP:0004311) | 2.24856240 |
| 67 | Recurrent sinusitis (HP:0011108) | 2.23291925 |
| 68 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.22680416 |
| 69 | Macular degeneration (HP:0000608) | 2.21881091 |
| 70 | Conjugated hyperbilirubinemia (HP:0002908) | 2.21073259 |
| 71 | Myositis (HP:0100614) | 2.20581597 |
| 72 | Severe visual impairment (HP:0001141) | 2.19654736 |
| 73 | Abnormality of incisor morphology (HP:0011063) | 2.16904691 |
| 74 | Abnormality of male internal genitalia (HP:0000022) | 2.11215543 |
| 75 | Abnormality of the pleura (HP:0002103) | 2.10577965 |
| 76 | Premature graying of hair (HP:0002216) | 2.07056680 |
| 77 | Recurrent otitis media (HP:0000403) | 2.05860932 |
| 78 | Nephrogenic diabetes insipidus (HP:0009806) | 2.04996661 |
| 79 | Anorexia (HP:0002039) | 2.04541672 |
| 80 | Amyotrophic lateral sclerosis (HP:0007354) | 2.04527810 |
| 81 | Dilatation of the ascending aorta (HP:0005111) | 2.04424359 |
| 82 | Pulmonary embolism (HP:0002204) | 2.03502139 |
| 83 | Agammaglobulinemia (HP:0004432) | 1.99942044 |
| 84 | Retinal dysplasia (HP:0007973) | 1.99394476 |
| 85 | Pigmentary retinal degeneration (HP:0001146) | 1.96680847 |
| 86 | Skin rash (HP:0000988) | 1.95841354 |
| 87 | Cellular immunodeficiency (HP:0005374) | 1.92817499 |
| 88 | Infantile muscular hypotonia (HP:0008947) | 1.88360364 |
| 89 | Granulocytopenia (HP:0001913) | 1.86361552 |
| 90 | Prominent nose (HP:0000448) | 1.84961511 |
| 91 | Recurrent skin infections (HP:0001581) | 1.82551039 |
| 92 | Lymphoma (HP:0002665) | 1.81084719 |
| 93 | Spastic diplegia (HP:0001264) | 1.77472623 |
| 94 | Renal tubular acidosis (HP:0001947) | 1.76983021 |
| 95 | Absent frontal sinuses (HP:0002688) | 1.76683383 |
| 96 | Autoimmune thrombocytopenia (HP:0001973) | 1.76456286 |
| 97 | Hypergammaglobulinemia (HP:0010702) | 1.74681324 |
| 98 | Recurrent bacterial skin infections (HP:0005406) | 1.74427508 |
| 99 | Abnormality of the pericardium (HP:0001697) | 1.73685933 |
| 100 | Glomerulopathy (HP:0100820) | 1.73046029 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 5.58889240 |
| 2 | MAP4K1 | 4.35684994 |
| 3 | ITK | 3.76675098 |
| 4 | TXK | 3.66157180 |
| 5 | TEC | 2.75972749 |
| 6 | MAP3K11 | 2.72826462 |
| 7 | CDK8 | 2.46571973 |
| 8 | TAOK3 | 2.43150636 |
| 9 | AKT3 | 2.31107171 |
| 10 | TESK2 | 2.29417314 |
| 11 | CSK | 2.26484398 |
| 12 | FRK | 2.15538766 |
| 13 | GRK6 | 2.09204602 |
| 14 | SYK | 1.99645296 |
| 15 | BTK | 1.96613144 |
| 16 | TBK1 | 1.91868368 |
| 17 | PRKCH | 1.86533765 |
| 18 | PRKCQ | 1.53671349 |
| 19 | IKBKE | 1.50581016 |
| 20 | TNK2 | 1.43294086 |
| 21 | PRKD2 | 1.43221425 |
| 22 | IRAK1 | 1.40122908 |
| 23 | ZAP70 | 1.39309427 |
| 24 | CDK4 | 1.39071913 |
| 25 | GRK5 | 1.35785900 |
| 26 | MAP3K7 | 1.35703297 |
| 27 | BUB1 | 1.29934462 |
| 28 | CSF1R | 1.29760889 |
| 29 | PIK3CG | 1.27191117 |
| 30 | MAP3K14 | 1.26167994 |
| 31 | JAK3 | 1.24186561 |
| 32 | DYRK1B | 1.19338138 |
| 33 | LCK | 1.18999797 |
| 34 | MAP2K6 | 1.18233223 |
| 35 | LYN | 1.13436234 |
| 36 | NUAK1 | 1.12260669 |
| 37 | BLK | 1.07490173 |
| 38 | MARK3 | 1.07005370 |
| 39 | MAP2K7 | 1.04795157 |
| 40 | FGFR1 | 0.97443350 |
| 41 | MELK | 0.96053065 |
| 42 | GRK1 | 0.93964156 |
| 43 | CDK9 | 0.92693461 |
| 44 | PLK2 | 0.91834542 |
| 45 | DYRK1A | 0.91546201 |
| 46 | MAP3K1 | 0.90975216 |
| 47 | IRAK4 | 0.90434698 |
| 48 | CAMKK2 | 0.88738069 |
| 49 | NLK | 0.87182610 |
| 50 | PRKD3 | 0.86838859 |
| 51 | SGK2 | 0.86781993 |
| 52 | ZAK | 0.79907240 |
| 53 | FES | 0.77663277 |
| 54 | IKBKB | 0.77395130 |
| 55 | STK4 | 0.76036875 |
| 56 | STK38 | 0.73387006 |
| 57 | VRK1 | 0.73282599 |
| 58 | BCR | 0.68634772 |
| 59 | ADRBK2 | 0.68473233 |
| 60 | IRAK2 | 0.63235338 |
| 61 | BRSK2 | 0.62254099 |
| 62 | SGK3 | 0.61306329 |
| 63 | AURKA | 0.59054923 |
| 64 | PKN1 | 0.58146725 |
| 65 | FYN | 0.51475241 |
| 66 | MARK2 | 0.50391706 |
| 67 | IGF1R | 0.49879087 |
| 68 | ACVR1B | 0.49638323 |
| 69 | ERBB3 | 0.48756796 |
| 70 | SGK223 | 0.48539621 |
| 71 | SGK494 | 0.48539621 |
| 72 | TRPM7 | 0.48107378 |
| 73 | PRKCE | 0.47693555 |
| 74 | PTK2B | 0.46066017 |
| 75 | ERN1 | 0.44648484 |
| 76 | RPS6KA5 | 0.44474487 |
| 77 | HCK | 0.44018895 |
| 78 | BMPR1B | 0.42319407 |
| 79 | PAK2 | 0.42096559 |
| 80 | PDGFRB | 0.38784645 |
| 81 | FGFR3 | 0.38706173 |
| 82 | PRKCA | 0.38469872 |
| 83 | TGFBR2 | 0.37618945 |
| 84 | FGFR2 | 0.36768486 |
| 85 | OBSCN | 0.36131549 |
| 86 | PRKCZ | 0.35805695 |
| 87 | ERBB2 | 0.35526257 |
| 88 | EGFR | 0.30645430 |
| 89 | TAF1 | 0.30430751 |
| 90 | GSK3A | 0.29510681 |
| 91 | INSR | 0.29269059 |
| 92 | PRKACA | 0.29148110 |
| 93 | INSRR | 0.29096824 |
| 94 | CAMKK1 | 0.28462079 |
| 95 | MAPKAPK2 | 0.28274758 |
| 96 | PRKCD | 0.28064872 |
| 97 | WNK4 | 0.27617023 |
| 98 | WNK1 | 0.27446507 |
| 99 | CAMK4 | 0.26474931 |
| 100 | LATS1 | 0.25932474 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.76586042 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.89995363 |
| 3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.94785582 |
| 4 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.89311124 |
| 5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.88648485 |
| 6 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.87499026 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.40429223 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.37962462 |
| 9 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 2.19469755 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.10790573 |
| 11 | Proteasome_Homo sapiens_hsa03050 | 2.02434427 |
| 12 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.93883934 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.85367984 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.83596111 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.81355697 |
| 16 | Salmonella infection_Homo sapiens_hsa05132 | 1.80669578 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.58979083 |
| 18 | Allograft rejection_Homo sapiens_hsa05330 | 1.54141116 |
| 19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.53184110 |
| 20 | Homologous recombination_Homo sapiens_hsa03440 | 1.51326606 |
| 21 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.50912690 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.33084462 |
| 23 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.31888824 |
| 24 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.22032037 |
| 25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.16883885 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.14694937 |
| 27 | Olfactory transduction_Homo sapiens_hsa04740 | 1.10372981 |
| 28 | Taste transduction_Homo sapiens_hsa04742 | 1.04774874 |
| 29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.01103205 |
| 30 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.98165822 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.97746891 |
| 32 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.95817108 |
| 33 | Malaria_Homo sapiens_hsa05144 | 0.95673945 |
| 34 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.93741098 |
| 35 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.93251794 |
| 36 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.92742988 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 0.91512575 |
| 38 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.88886277 |
| 39 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.88869004 |
| 40 | Parkinsons disease_Homo sapiens_hsa05012 | 0.87577166 |
| 41 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.83427096 |
| 42 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.83204154 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.80595465 |
| 44 | Mismatch repair_Homo sapiens_hsa03430 | 0.77976221 |
| 45 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.72495598 |
| 46 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.72252321 |
| 47 | Renin secretion_Homo sapiens_hsa04924 | 0.71967858 |
| 48 | Phototransduction_Homo sapiens_hsa04744 | 0.70083652 |
| 49 | Colorectal cancer_Homo sapiens_hsa05210 | 0.69184597 |
| 50 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66681637 |
| 51 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.62865222 |
| 52 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.60267835 |
| 53 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.59509297 |
| 54 | Melanoma_Homo sapiens_hsa05218 | 0.58072230 |
| 55 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.56893052 |
| 56 | Alzheimers disease_Homo sapiens_hsa05010 | 0.56086687 |
| 57 | Long-term potentiation_Homo sapiens_hsa04720 | 0.55838747 |
| 58 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.54906975 |
| 59 | Protein export_Homo sapiens_hsa03060 | 0.54288223 |
| 60 | HTLV-I infection_Homo sapiens_hsa05166 | 0.54263574 |
| 61 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.53392387 |
| 62 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.52364606 |
| 63 | Leishmaniasis_Homo sapiens_hsa05140 | 0.52304693 |
| 64 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.52101986 |
| 65 | Alcoholism_Homo sapiens_hsa05034 | 0.51147882 |
| 66 | Apoptosis_Homo sapiens_hsa04210 | 0.49931546 |
| 67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49903591 |
| 68 | Platelet activation_Homo sapiens_hsa04611 | 0.49493908 |
| 69 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.49461156 |
| 70 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.47880526 |
| 71 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.46705124 |
| 72 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.45085692 |
| 73 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.44571006 |
| 74 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.44325581 |
| 75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.40894625 |
| 76 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.40550227 |
| 77 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39888348 |
| 78 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.39423585 |
| 79 | Endocytosis_Homo sapiens_hsa04144 | 0.38983961 |
| 80 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.38296486 |
| 81 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38049339 |
| 82 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.36174663 |
| 83 | Hepatitis B_Homo sapiens_hsa05161 | 0.35459788 |
| 84 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.34474750 |
| 85 | Glioma_Homo sapiens_hsa05214 | 0.34106267 |
| 86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.33442717 |
| 87 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.31235959 |
| 88 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.30302596 |
| 89 | Viral myocarditis_Homo sapiens_hsa05416 | 0.28684214 |
| 90 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.27126180 |
| 91 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.26064024 |
| 92 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.25932143 |
| 93 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.25094646 |
| 94 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.25006113 |
| 95 | Huntingtons disease_Homo sapiens_hsa05016 | 0.23220260 |
| 96 | Pertussis_Homo sapiens_hsa05133 | 0.23124473 |
| 97 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.22875025 |
| 98 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.22861038 |
| 99 | Legionellosis_Homo sapiens_hsa05134 | 0.21904346 |
| 100 | RNA degradation_Homo sapiens_hsa03018 | 0.21136902 |

